4-Benzyloxylonchocarpin and muracatanes A-C from Ranunculus muricatus L. and their biological effects

Hidayat Hussain*, Iftikhar Ali, Daijie Wang, Nilufar Z. Mamadalieva, Wahid Hussain, René Csuk, Anne Loesche, Lucie Fischer, Dan Stærk, Syariful Anam, Mashail N. AlZain, Maria Mushtaq, Zaheer Ul-Haq, Riaz Ullah, Omar M. Noman, Ghulam Abbas, Ivan R. Green

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

9 Citationer (Scopus)
49 Downloads (Pure)

Abstract

Ranunculus muricatus L. is a spiny fruit buttercup that is used in various traditional medicinal systems. In the current investigation of R. muricatus, the new chalcone 4-benzyloxylonchocarpin (1), the new anthraquinone muracatanes A (2), the new-to-nature anthraquinone muracatanes B (3), and the
new naphthalene analog muracatanes C (4) were isolated, in addition to the three previously reported
compounds, 4-methoxylonchocarpin (5), β-sitosterol (6), and β-sitosterol β-D-glucopyranoside (7). Their structures were elucidated using 1D (1H and 13C) and 2D (COSY, HSQC, and HMBC) NMR
spectroscopy and HR-ESI-MS. Chalcone 1 showed potent acetylcholinesterase inhibitory effects with
Ki of 5.39 μM and Ki' of 3.54 μM, but none of the isolated compounds showed inhibitory activity
towards butyrylcholinesterase. Anthraquinone 3 illustrated α-glucosidase inhibitory effects with
IC50-values of 164.46 ± 83.04 μM. Compound 5 displayed moderate cytotoxic activity towards ovarian carcinoma (A2780, IC50 = 25.4 μM), colorectal adenocarcinoma (HT29, IC50 = 20.2 μM), breast cancer (MCF7, IC50 = 23.7 μM), and thyroid carcinoma (SW1736, IC50 = 26.2 μM) while it was inactive towards pharynx carcinoma (FaDu: IC50 > 30 μM).
OriginalsprogEngelsk
Artikelnummer1562
TidsskriftBiomolecules
Vol/bind10
Udgave nummer11
Antal sider15
ISSN2218-273X
DOI
StatusUdgivet - 2020

Citationsformater